These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 35908886)
1. Picropodophyllin Inhibits the Proliferation of Human Prostate Cancer DU145 and LNCaP Cells via ROS Production and PI3K/AKT Pathway Inhibition. Zhu X; Chen X; Wang G; Lei D; Chen X; Lin K; Li M; Lin H; Li D; Zheng Q Biol Pharm Bull; 2022; 45(8):1027-1035. PubMed ID: 35908886 [TBL] [Abstract][Full Text] [Related]
2. Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells. Harashima N; Inao T; Imamura R; Okano S; Suda T; Harada M Cancer Immunol Immunother; 2012 May; 61(5):667-76. PubMed ID: 22038398 [TBL] [Abstract][Full Text] [Related]
3. Picropodophyllin inhibits type I endometrial cancer cell proliferation via disruption of the PI3K/Akt pathway. Dong L; Du M; Lv Q Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):753-760. PubMed ID: 31168597 [TBL] [Abstract][Full Text] [Related]
4. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells. Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210 [TBL] [Abstract][Full Text] [Related]
5. Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway. Li X; Song Y; Zhang P; Zhu H; Chen L; Xiao Y; Xing Y Tumour Biol; 2016 Jun; 37(6):7599-613. PubMed ID: 26687646 [TBL] [Abstract][Full Text] [Related]
6. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells. Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465 [TBL] [Abstract][Full Text] [Related]
7. Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells. Strömberg T; Feng X; Delforoush M; Berglund M; Lin Y; Axelson M; Larsson O; Georgii-Hemming P; Lennartsson J; Enblad G Med Oncol; 2015 Jul; 32(7):188. PubMed ID: 26021470 [TBL] [Abstract][Full Text] [Related]
8. [Chinese medicinal compound CFF-1 induces the apoptosis and cycle-arrest of prostate cancer cells via the PI3K/AKT/FOXO1 signaling pathway]. Zhang Y; Wu ZM; Lei BH; Lu ZJ; Zhu QY; Xu FS; Zhang MS; Liu P Zhonghua Nan Ke Xue; 2017 Sep; 23(9):828-837. PubMed ID: 29726666 [TBL] [Abstract][Full Text] [Related]
9. Fraxetin down-regulates polo-like kinase 4 (PLK4) to inhibit proliferation, migration and invasion of prostate cancer cells through the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway. Ma Z; Sun Y; Peng W Bioengineered; 2022 Apr; 13(4):9345-9356. PubMed ID: 35387563 [TBL] [Abstract][Full Text] [Related]
10. The toxicity mechanism of glabridin in prostate cancer cells is involved in reactive oxygen species-dependent PI3K/Akt pathway: Integrated utilization of bioinformatic analysis and in vitro test validation. Zhang F; Wang F; Li W; Liang L; Sang X Environ Toxicol; 2022 Dec; 37(12):2937-2946. PubMed ID: 36029289 [TBL] [Abstract][Full Text] [Related]
11. Sinodielide A exerts thermosensitizing effects and induces apoptosis and G2/M cell cycle arrest in DU145 human prostate cancer cells via the Ras/Raf/MAPK and PI3K/Akt signaling pathways. Hatashita M; Taniguchi M; Baba K; Koshiba K; Sato T; Jujo Y; Suzuki R; Hayashi S Int J Mol Med; 2014 Feb; 33(2):406-14. PubMed ID: 24285252 [TBL] [Abstract][Full Text] [Related]
12. Chidamide Inhibits Cell Proliferation via the PI3K/AKT Pathway in K562 Cells Based on Network Pharmacology and Experimental Validation. Liang S; Zhou X; Cai D; Rodrigues-Lima F; Wang L Curr Pharm Des; 2021; 27(26):2990-2998. PubMed ID: 34218775 [TBL] [Abstract][Full Text] [Related]
13. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway. Liang F; Yue J; Wang J; Zhang L; Fan R; Zhang H; Zhang Q Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507 [TBL] [Abstract][Full Text] [Related]
14. The association of TP53 mutations with the resistance of colorectal carcinoma to the insulin-like growth factor-1 receptor inhibitor picropodophyllin. Wang Q; Wei F; Lv G; Li C; Liu T; Hadjipanayis CG; Zhang G; Hao C; Bellail AC BMC Cancer; 2013 Nov; 13():521. PubMed ID: 24182354 [TBL] [Abstract][Full Text] [Related]
15. Sparstolonin B exerts beneficial effects on prostate cancer by acting on the reactive oxygen species-mediated PI3K/AKT pathway. Liu S; Hu J; Shi C; Sun L; Yan W; Song Y J Cell Mol Med; 2021 Jun; 25(12):5511-5524. PubMed ID: 33951324 [TBL] [Abstract][Full Text] [Related]
16. Naringenin-Induced Apoptotic Cell Death in Prostate Cancer Cells Is Mediated via the PI3K/AKT and MAPK Signaling Pathways. Lim W; Park S; Bazer FW; Song G J Cell Biochem; 2017 May; 118(5):1118-1131. PubMed ID: 27606834 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway. Miyake H; Nelson C; Rennie PS; Gleave ME Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316 [TBL] [Abstract][Full Text] [Related]
18. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway. Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811 [TBL] [Abstract][Full Text] [Related]
19. Ursolic Acid Induces Apoptosis of Prostate Cancer Cells via the PI3K/Akt/mTOR Pathway. Meng Y; Lin ZM; Ge N; Zhang DL; Huang J; Kong F Am J Chin Med; 2015; 43(7):1471-86. PubMed ID: 26503559 [TBL] [Abstract][Full Text] [Related]
20. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]